Replies to post #16013 on Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Nasdag/US F1 on 5-9 was for 45 days, ending 6-24?
CSE only for this F1?
Different requirements, registration and costs?
Until AGN gets something from UK MHRA about the Stroke initiative or from FDA for CC or oncology it's hard work and they need funds to pursue this all.?.
It seems that re-writing parts of the applications and/or specifics about the Trials are still in work.
Oncology and Stroke are tough areas. IPF/CC may be first. I had hope for quick UK Trial support and strong interest in Australia to continue the IPF/CC work. I hope applications to cancer foundation were made.
I'm not selling at these tree shakes at this point, stubborn and holding to see all the cards. < .003% of OS = -20+%?.........

...GLTA...